LymphedemaV1, PubMed, Checkpoint, bibRecord, 000978

Controlling Neglected Tropical Diseases (NTDs) in Haiti: Implementation Strategies and Evidence of Their Success.

Identifieur interne : 000978 ( PubMed/Checkpoint ); précédent : 000977; suivant : 000979

Controlling Neglected Tropical Diseases (NTDs) in Haiti: Implementation Strategies and Evidence of Their Success.

Auteurs : Jean Frantz Lemoine [Haïti] ; Anne Marie Desormeaux [Haïti] ; Franck Monestime [Haïti] ; Carl Renad Fayette [Haïti] ; Luccene Desir [Haïti] ; Abdel Nasser Direny [États-Unis] ; Sarah Carciunoiu [États-Unis] ; Lior Miller [États-Unis] ; Alaine Knipes [États-Unis] ; Patrick Lammie [États-Unis] ; Penelope Smith [États-Unis] ; Melissa Stockton [États-Unis] ; Lily Trofimovich [États-Unis] ; Kalpana Bhandari [États-Unis] ; Richard Reithinger [États-Unis] ; Kathryn Crowley [États-Unis] ; Eric Ottesen [États-Unis] ; Margaret Baker [États-Unis]

Source :

PLoS neglected tropical diseases [ 1935-2735 ] ; 2016.

RBID : pubmed:27706162

Descripteurs français

KwdFr :
- Albendazole (administration et posologie), Albendazole (usage thérapeutique), Animaux, Antihelminthiques (administration et posologie), Antihelminthiques (usage thérapeutique), Diéthylcarbamazine (administration et posologie), Diéthylcarbamazine (usage thérapeutique), Filaricides (administration et posologie), Filaricides (usage thérapeutique), Filariose lymphatique (), Filariose lymphatique (parasitologie), Filariose lymphatique (traitement médicamenteux), Filariose lymphatique (épidémiologie), Haïti (épidémiologie), Helminthes (), Helminthes (isolement et purification), Helminthiase (), Helminthiase (parasitologie), Helminthiase (traitement médicamenteux), Helminthiase (épidémiologie), Humains, Maladies négligées (), Maladies négligées (parasitologie), Maladies négligées (épidémiologie), Santé publique (), Santé publique (normes).
MESH :
- administration et posologie : Albendazole, Antihelminthiques, Diéthylcarbamazine, Filaricides.
- isolement et purification : Helminthes.
- normes : Santé publique.
- parasitologie : Filariose lymphatique, Helminthiase, Maladies négligées.
- traitement médicamenteux : Filariose lymphatique, Helminthiase.
- usage thérapeutique : Albendazole, Antihelminthiques, Diéthylcarbamazine, Filaricides.
- épidémiologie : Filariose lymphatique, Haïti, Helminthiase, Maladies négligées.
- Animaux, Filariose lymphatique, Helminthes, Helminthiase, Humains, Maladies négligées, Santé publique.

English descriptors

KwdEn :
- Albendazole (administration & dosage), Albendazole (therapeutic use), Animals, Anthelmintics (administration & dosage), Anthelmintics (therapeutic use), Diethylcarbamazine (administration & dosage), Diethylcarbamazine (therapeutic use), Elephantiasis, Filarial (drug therapy), Elephantiasis, Filarial (epidemiology), Elephantiasis, Filarial (parasitology), Elephantiasis, Filarial (prevention & control), Filaricides (administration & dosage), Filaricides (therapeutic use), Haiti (epidemiology), Helminthiasis (drug therapy), Helminthiasis (epidemiology), Helminthiasis (parasitology), Helminthiasis (prevention & control), Helminths (drug effects), Helminths (isolation & purification), Humans, Neglected Diseases (epidemiology), Neglected Diseases (parasitology), Neglected Diseases (prevention & control), Neglected Diseases (therapy), Public Health (methods), Public Health (standards), Public Health (statistics & numerical data).
MESH :
- chemical , administration & dosage : Albendazole, Anthelmintics, Diethylcarbamazine, Filaricides.
- chemical , therapeutic use : Albendazole, Anthelmintics, Diethylcarbamazine, Filaricides.
- drug effects : Helminths.
- drug therapy : Elephantiasis, Filarial, Helminthiasis.
- epidemiology : Elephantiasis, Filarial, Haiti, Helminthiasis, Neglected Diseases.
- isolation & purification : Helminths.
- methods : Public Health.
- parasitology : Elephantiasis, Filarial, Helminthiasis, Neglected Diseases.
- prevention & control : Elephantiasis, Filarial, Helminthiasis, Neglected Diseases.
- standards : Public Health.
- statistics & numerical data : Public Health.
- therapy : Neglected Diseases.
- Animals, Humans.

Abstract

Lymphatic filariasis (LF) and soil-transmitted helminths (STH) have been targeted since 2000 in Haiti, with a strong mass drug administration (MDA) program led by the Ministry of Public Health and Population and its collaborating international partners. By 2012, Haiti's neglected tropical disease (NTD) program had reached full national scale, and with such consistently good epidemiological coverage that it is now able to stop treatment for LF throughout almost all of the country. Essential to this success have been in the detail of how MDAs were implemented. These key programmatic elements included ensuring strong community awareness through an evidence-based, multi-channel communication and education campaign facilitated by voluntary drug distributors; strengthening community trust of the drug distributors by ensuring that respected community members were recruited and received appropriate training, supervision, identification, and motivation; enforcing a "directly observed treatment" strategy; providing easy access to treatment though numerous distribution posts and a strong drug supply chain; and ensuring quality data collection that was used to guide and inform MDA strategies. The evidence that these strategies were effective lies in both the high treatment coverage obtained- 100% geographical coverage reached in 2012, with almost all districts consistently achieving well above the epidemiological coverage targets of 65% for LF and 75% for STH-and the significant reduction in burden of infection- 45 communes having reached the target threshold for stopping treatment for LF. By taking advantage of sustained international financial and technical support, especially during the past eight years, Haiti's very successful MDA campaign resulted in steady progress toward LF elimination and development of a strong foundation for ongoing STH control. These efforts, as described, have not only helped establish the global portfolio of "best practices" for NTD control but also are poised to help solve two of the most important future NTD challenges-how to maintain control of STH infections after the community-based LF "treatment platform" ceases and how to ensure appropriate morbidity management for patients currently suffering from lymphatic filarial disease.

DOI: 10.1371/journal.pntd.0004954
PubMed: 27706162

Affiliations:

Links toward previous steps (curation, corpus...)

to stream PubMed, to step Corpus: 000594
to stream PubMed, to step Curation: 000594

Links to Exploration step

pubmed:27706162

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Controlling Neglected Tropical Diseases (NTDs) in Haiti: Implementation Strategies and Evidence of Their Success.</title>
<author><name sortKey="Lemoine, Jean Frantz" sort="Lemoine, Jean Frantz" uniqKey="Lemoine J" first="Jean Frantz" last="Lemoine">Jean Frantz Lemoine</name>
<affiliation wicri:level="1"><nlm:affiliation>Ministry of Public Health and Population, Port-au-Prince, Haiti.</nlm:affiliation>
<country xml:lang="fr">Haïti</country>
<wicri:regionArea>Ministry of Public Health and Population, Port-au-Prince</wicri:regionArea>
<wicri:noRegion>Port-au-Prince</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Desormeaux, Anne Marie" sort="Desormeaux, Anne Marie" uniqKey="Desormeaux A" first="Anne Marie" last="Desormeaux">Anne Marie Desormeaux</name>
<affiliation wicri:level="1"><nlm:affiliation>Ministry of Public Health and Population, Port-au-Prince, Haiti.</nlm:affiliation>
<country xml:lang="fr">Haïti</country>
<wicri:regionArea>Ministry of Public Health and Population, Port-au-Prince</wicri:regionArea>
<wicri:noRegion>Port-au-Prince</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Monestime, Franck" sort="Monestime, Franck" uniqKey="Monestime F" first="Franck" last="Monestime">Franck Monestime</name>
<affiliation wicri:level="1"><nlm:affiliation>IMA World Health, Port-au-Prince, Haiti.</nlm:affiliation>
<country xml:lang="fr">Haïti</country>
<wicri:regionArea>IMA World Health, Port-au-Prince</wicri:regionArea>
<wicri:noRegion>Port-au-Prince</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Fayette, Carl Renad" sort="Fayette, Carl Renad" uniqKey="Fayette C" first="Carl Renad" last="Fayette">Carl Renad Fayette</name>
<affiliation wicri:level="1"><nlm:affiliation>IMA World Health, Port-au-Prince, Haiti.</nlm:affiliation>
<country xml:lang="fr">Haïti</country>
<wicri:regionArea>IMA World Health, Port-au-Prince</wicri:regionArea>
<wicri:noRegion>Port-au-Prince</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Desir, Luccene" sort="Desir, Luccene" uniqKey="Desir L" first="Luccene" last="Desir">Luccene Desir</name>
<affiliation wicri:level="1"><nlm:affiliation>Hôpital Sainte Croix, Léogâne, Haiti.</nlm:affiliation>
<country xml:lang="fr">Haïti</country>
<wicri:regionArea>Hôpital Sainte Croix, Léogâne</wicri:regionArea>
<wicri:noRegion>Léogâne</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Direny, Abdel Nasser" sort="Direny, Abdel Nasser" uniqKey="Direny A" first="Abdel Nasser" last="Direny">Abdel Nasser Direny</name>
<affiliation wicri:level="1"><nlm:affiliation>RTI International, Washington, District of Columbia, United States of America.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>RTI International, Washington, District of Columbia</wicri:regionArea>
<wicri:noRegion>District of Columbia</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Carciunoiu, Sarah" sort="Carciunoiu, Sarah" uniqKey="Carciunoiu S" first="Sarah" last="Carciunoiu">Sarah Carciunoiu</name>
<affiliation wicri:level="1"><nlm:affiliation>IMA World Health, Washington, District of Columbia, United States of America.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>IMA World Health, Washington, District of Columbia</wicri:regionArea>
<wicri:noRegion>District of Columbia</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Miller, Lior" sort="Miller, Lior" uniqKey="Miller L" first="Lior" last="Miller">Lior Miller</name>
<affiliation wicri:level="1"><nlm:affiliation>IMA World Health, Washington, District of Columbia, United States of America.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>IMA World Health, Washington, District of Columbia</wicri:regionArea>
<wicri:noRegion>District of Columbia</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Knipes, Alaine" sort="Knipes, Alaine" uniqKey="Knipes A" first="Alaine" last="Knipes">Alaine Knipes</name>
<affiliation wicri:level="2"><nlm:affiliation>Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Centers for Disease Control and Prevention, Atlanta, Georgia</wicri:regionArea>
<placeName><region type="state">Géorgie (États-Unis)</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Lammie, Patrick" sort="Lammie, Patrick" uniqKey="Lammie P" first="Patrick" last="Lammie">Patrick Lammie</name>
<affiliation wicri:level="2"><nlm:affiliation>Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Centers for Disease Control and Prevention, Atlanta, Georgia</wicri:regionArea>
<placeName><region type="state">Géorgie (États-Unis)</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Smith, Penelope" sort="Smith, Penelope" uniqKey="Smith P" first="Penelope" last="Smith">Penelope Smith</name>
<affiliation wicri:level="1"><nlm:affiliation>U.S. Agency for International Development, Washington, District of Columbia, United States of America.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>U.S. Agency for International Development, Washington, District of Columbia</wicri:regionArea>
<wicri:noRegion>District of Columbia</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Stockton, Melissa" sort="Stockton, Melissa" uniqKey="Stockton M" first="Melissa" last="Stockton">Melissa Stockton</name>
<affiliation wicri:level="1"><nlm:affiliation>RTI International, Washington, District of Columbia, United States of America.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>RTI International, Washington, District of Columbia</wicri:regionArea>
<wicri:noRegion>District of Columbia</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Trofimovich, Lily" sort="Trofimovich, Lily" uniqKey="Trofimovich L" first="Lily" last="Trofimovich">Lily Trofimovich</name>
<affiliation wicri:level="1"><nlm:affiliation>RTI International Consultancy, Washington, District of Columbia, United States of America.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>RTI International Consultancy, Washington, District of Columbia</wicri:regionArea>
<wicri:noRegion>District of Columbia</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Bhandari, Kalpana" sort="Bhandari, Kalpana" uniqKey="Bhandari K" first="Kalpana" last="Bhandari">Kalpana Bhandari</name>
<affiliation wicri:level="1"><nlm:affiliation>RTI International, Washington, District of Columbia, United States of America.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>RTI International, Washington, District of Columbia</wicri:regionArea>
<wicri:noRegion>District of Columbia</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Reithinger, Richard" sort="Reithinger, Richard" uniqKey="Reithinger R" first="Richard" last="Reithinger">Richard Reithinger</name>
<affiliation wicri:level="1"><nlm:affiliation>RTI International, Washington, District of Columbia, United States of America.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>RTI International, Washington, District of Columbia</wicri:regionArea>
<wicri:noRegion>District of Columbia</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Crowley, Kathryn" sort="Crowley, Kathryn" uniqKey="Crowley K" first="Kathryn" last="Crowley">Kathryn Crowley</name>
<affiliation wicri:level="1"><nlm:affiliation>RTI International, Washington, District of Columbia, United States of America.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>RTI International, Washington, District of Columbia</wicri:regionArea>
<wicri:noRegion>District of Columbia</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Ottesen, Eric" sort="Ottesen, Eric" uniqKey="Ottesen E" first="Eric" last="Ottesen">Eric Ottesen</name>
<affiliation wicri:level="1"><nlm:affiliation>RTI International, Washington, District of Columbia, United States of America.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>RTI International, Washington, District of Columbia</wicri:regionArea>
<wicri:noRegion>District of Columbia</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Baker, Margaret" sort="Baker, Margaret" uniqKey="Baker M" first="Margaret" last="Baker">Margaret Baker</name>
<affiliation wicri:level="1"><nlm:affiliation>RTI International, Washington, District of Columbia, United States of America.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>RTI International, Washington, District of Columbia</wicri:regionArea>
<wicri:noRegion>District of Columbia</wicri:noRegion>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2016">2016</date>
<idno type="RBID">pubmed:27706162</idno>
<idno type="pmid">27706162</idno>
<idno type="doi">10.1371/journal.pntd.0004954</idno>
<idno type="wicri:Area/PubMed/Corpus">000594</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000594</idno>
<idno type="wicri:Area/PubMed/Curation">000594</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000594</idno>
<idno type="wicri:Area/PubMed/Checkpoint">000594</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000594</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Controlling Neglected Tropical Diseases (NTDs) in Haiti: Implementation Strategies and Evidence of Their Success.</title>
<author><name sortKey="Lemoine, Jean Frantz" sort="Lemoine, Jean Frantz" uniqKey="Lemoine J" first="Jean Frantz" last="Lemoine">Jean Frantz Lemoine</name>
<affiliation wicri:level="1"><nlm:affiliation>Ministry of Public Health and Population, Port-au-Prince, Haiti.</nlm:affiliation>
<country xml:lang="fr">Haïti</country>
<wicri:regionArea>Ministry of Public Health and Population, Port-au-Prince</wicri:regionArea>
<wicri:noRegion>Port-au-Prince</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Desormeaux, Anne Marie" sort="Desormeaux, Anne Marie" uniqKey="Desormeaux A" first="Anne Marie" last="Desormeaux">Anne Marie Desormeaux</name>
<affiliation wicri:level="1"><nlm:affiliation>Ministry of Public Health and Population, Port-au-Prince, Haiti.</nlm:affiliation>
<country xml:lang="fr">Haïti</country>
<wicri:regionArea>Ministry of Public Health and Population, Port-au-Prince</wicri:regionArea>
<wicri:noRegion>Port-au-Prince</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Monestime, Franck" sort="Monestime, Franck" uniqKey="Monestime F" first="Franck" last="Monestime">Franck Monestime</name>
<affiliation wicri:level="1"><nlm:affiliation>IMA World Health, Port-au-Prince, Haiti.</nlm:affiliation>
<country xml:lang="fr">Haïti</country>
<wicri:regionArea>IMA World Health, Port-au-Prince</wicri:regionArea>
<wicri:noRegion>Port-au-Prince</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Fayette, Carl Renad" sort="Fayette, Carl Renad" uniqKey="Fayette C" first="Carl Renad" last="Fayette">Carl Renad Fayette</name>
<affiliation wicri:level="1"><nlm:affiliation>IMA World Health, Port-au-Prince, Haiti.</nlm:affiliation>
<country xml:lang="fr">Haïti</country>
<wicri:regionArea>IMA World Health, Port-au-Prince</wicri:regionArea>
<wicri:noRegion>Port-au-Prince</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Desir, Luccene" sort="Desir, Luccene" uniqKey="Desir L" first="Luccene" last="Desir">Luccene Desir</name>
<affiliation wicri:level="1"><nlm:affiliation>Hôpital Sainte Croix, Léogâne, Haiti.</nlm:affiliation>
<country xml:lang="fr">Haïti</country>
<wicri:regionArea>Hôpital Sainte Croix, Léogâne</wicri:regionArea>
<wicri:noRegion>Léogâne</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Direny, Abdel Nasser" sort="Direny, Abdel Nasser" uniqKey="Direny A" first="Abdel Nasser" last="Direny">Abdel Nasser Direny</name>
<affiliation wicri:level="1"><nlm:affiliation>RTI International, Washington, District of Columbia, United States of America.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>RTI International, Washington, District of Columbia</wicri:regionArea>
<wicri:noRegion>District of Columbia</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Carciunoiu, Sarah" sort="Carciunoiu, Sarah" uniqKey="Carciunoiu S" first="Sarah" last="Carciunoiu">Sarah Carciunoiu</name>
<affiliation wicri:level="1"><nlm:affiliation>IMA World Health, Washington, District of Columbia, United States of America.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>IMA World Health, Washington, District of Columbia</wicri:regionArea>
<wicri:noRegion>District of Columbia</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Miller, Lior" sort="Miller, Lior" uniqKey="Miller L" first="Lior" last="Miller">Lior Miller</name>
<affiliation wicri:level="1"><nlm:affiliation>IMA World Health, Washington, District of Columbia, United States of America.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>IMA World Health, Washington, District of Columbia</wicri:regionArea>
<wicri:noRegion>District of Columbia</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Knipes, Alaine" sort="Knipes, Alaine" uniqKey="Knipes A" first="Alaine" last="Knipes">Alaine Knipes</name>
<affiliation wicri:level="2"><nlm:affiliation>Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Centers for Disease Control and Prevention, Atlanta, Georgia</wicri:regionArea>
<placeName><region type="state">Géorgie (États-Unis)</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Lammie, Patrick" sort="Lammie, Patrick" uniqKey="Lammie P" first="Patrick" last="Lammie">Patrick Lammie</name>
<affiliation wicri:level="2"><nlm:affiliation>Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Centers for Disease Control and Prevention, Atlanta, Georgia</wicri:regionArea>
<placeName><region type="state">Géorgie (États-Unis)</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Smith, Penelope" sort="Smith, Penelope" uniqKey="Smith P" first="Penelope" last="Smith">Penelope Smith</name>
<affiliation wicri:level="1"><nlm:affiliation>U.S. Agency for International Development, Washington, District of Columbia, United States of America.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>U.S. Agency for International Development, Washington, District of Columbia</wicri:regionArea>
<wicri:noRegion>District of Columbia</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Stockton, Melissa" sort="Stockton, Melissa" uniqKey="Stockton M" first="Melissa" last="Stockton">Melissa Stockton</name>
<affiliation wicri:level="1"><nlm:affiliation>RTI International, Washington, District of Columbia, United States of America.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>RTI International, Washington, District of Columbia</wicri:regionArea>
<wicri:noRegion>District of Columbia</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Trofimovich, Lily" sort="Trofimovich, Lily" uniqKey="Trofimovich L" first="Lily" last="Trofimovich">Lily Trofimovich</name>
<affiliation wicri:level="1"><nlm:affiliation>RTI International Consultancy, Washington, District of Columbia, United States of America.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>RTI International Consultancy, Washington, District of Columbia</wicri:regionArea>
<wicri:noRegion>District of Columbia</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Bhandari, Kalpana" sort="Bhandari, Kalpana" uniqKey="Bhandari K" first="Kalpana" last="Bhandari">Kalpana Bhandari</name>
<affiliation wicri:level="1"><nlm:affiliation>RTI International, Washington, District of Columbia, United States of America.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>RTI International, Washington, District of Columbia</wicri:regionArea>
<wicri:noRegion>District of Columbia</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Reithinger, Richard" sort="Reithinger, Richard" uniqKey="Reithinger R" first="Richard" last="Reithinger">Richard Reithinger</name>
<affiliation wicri:level="1"><nlm:affiliation>RTI International, Washington, District of Columbia, United States of America.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>RTI International, Washington, District of Columbia</wicri:regionArea>
<wicri:noRegion>District of Columbia</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Crowley, Kathryn" sort="Crowley, Kathryn" uniqKey="Crowley K" first="Kathryn" last="Crowley">Kathryn Crowley</name>
<affiliation wicri:level="1"><nlm:affiliation>RTI International, Washington, District of Columbia, United States of America.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>RTI International, Washington, District of Columbia</wicri:regionArea>
<wicri:noRegion>District of Columbia</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Ottesen, Eric" sort="Ottesen, Eric" uniqKey="Ottesen E" first="Eric" last="Ottesen">Eric Ottesen</name>
<affiliation wicri:level="1"><nlm:affiliation>RTI International, Washington, District of Columbia, United States of America.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>RTI International, Washington, District of Columbia</wicri:regionArea>
<wicri:noRegion>District of Columbia</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Baker, Margaret" sort="Baker, Margaret" uniqKey="Baker M" first="Margaret" last="Baker">Margaret Baker</name>
<affiliation wicri:level="1"><nlm:affiliation>RTI International, Washington, District of Columbia, United States of America.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>RTI International, Washington, District of Columbia</wicri:regionArea>
<wicri:noRegion>District of Columbia</wicri:noRegion>
</affiliation>
</author>
</analytic>
<series><title level="j">PLoS neglected tropical diseases</title>
<idno type="eISSN">1935-2735</idno>
<imprint><date when="2016" type="published">2016</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Albendazole (administration & dosage)</term>
<term>Albendazole (therapeutic use)</term>
<term>Animals</term>
<term>Anthelmintics (administration & dosage)</term>
<term>Anthelmintics (therapeutic use)</term>
<term>Diethylcarbamazine (administration & dosage)</term>
<term>Diethylcarbamazine (therapeutic use)</term>
<term>Elephantiasis, Filarial (drug therapy)</term>
<term>Elephantiasis, Filarial (epidemiology)</term>
<term>Elephantiasis, Filarial (parasitology)</term>
<term>Elephantiasis, Filarial (prevention & control)</term>
<term>Filaricides (administration & dosage)</term>
<term>Filaricides (therapeutic use)</term>
<term>Haiti (epidemiology)</term>
<term>Helminthiasis (drug therapy)</term>
<term>Helminthiasis (epidemiology)</term>
<term>Helminthiasis (parasitology)</term>
<term>Helminthiasis (prevention & control)</term>
<term>Helminths (drug effects)</term>
<term>Helminths (isolation & purification)</term>
<term>Humans</term>
<term>Neglected Diseases (epidemiology)</term>
<term>Neglected Diseases (parasitology)</term>
<term>Neglected Diseases (prevention & control)</term>
<term>Neglected Diseases (therapy)</term>
<term>Public Health (methods)</term>
<term>Public Health (standards)</term>
<term>Public Health (statistics & numerical data)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Albendazole (administration et posologie)</term>
<term>Albendazole (usage thérapeutique)</term>
<term>Animaux</term>
<term>Antihelminthiques (administration et posologie)</term>
<term>Antihelminthiques (usage thérapeutique)</term>
<term>Diéthylcarbamazine (administration et posologie)</term>
<term>Diéthylcarbamazine (usage thérapeutique)</term>
<term>Filaricides (administration et posologie)</term>
<term>Filaricides (usage thérapeutique)</term>
<term>Filariose lymphatique ()</term>
<term>Filariose lymphatique (parasitologie)</term>
<term>Filariose lymphatique (traitement médicamenteux)</term>
<term>Filariose lymphatique (épidémiologie)</term>
<term>Haïti (épidémiologie)</term>
<term>Helminthes ()</term>
<term>Helminthes (isolement et purification)</term>
<term>Helminthiase ()</term>
<term>Helminthiase (parasitologie)</term>
<term>Helminthiase (traitement médicamenteux)</term>
<term>Helminthiase (épidémiologie)</term>
<term>Humains</term>
<term>Maladies négligées ()</term>
<term>Maladies négligées (parasitologie)</term>
<term>Maladies négligées (épidémiologie)</term>
<term>Santé publique ()</term>
<term>Santé publique (normes)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Albendazole</term>
<term>Anthelmintics</term>
<term>Diethylcarbamazine</term>
<term>Filaricides</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Albendazole</term>
<term>Anthelmintics</term>
<term>Diethylcarbamazine</term>
<term>Filaricides</term>
</keywords>
<keywords scheme="MESH" qualifier="administration et posologie" xml:lang="fr"><term>Albendazole</term>
<term>Antihelminthiques</term>
<term>Diéthylcarbamazine</term>
<term>Filaricides</term>
</keywords>
<keywords scheme="MESH" qualifier="drug effects" xml:lang="en"><term>Helminths</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Elephantiasis, Filarial</term>
<term>Helminthiasis</term>
</keywords>
<keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Elephantiasis, Filarial</term>
<term>Haiti</term>
<term>Helminthiasis</term>
<term>Neglected Diseases</term>
</keywords>
<keywords scheme="MESH" qualifier="isolation & purification" xml:lang="en"><term>Helminths</term>
</keywords>
<keywords scheme="MESH" qualifier="isolement et purification" xml:lang="fr"><term>Helminthes</term>
</keywords>
<keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Public Health</term>
</keywords>
<keywords scheme="MESH" qualifier="normes" xml:lang="fr"><term>Santé publique</term>
</keywords>
<keywords scheme="MESH" qualifier="parasitologie" xml:lang="fr"><term>Filariose lymphatique</term>
<term>Helminthiase</term>
<term>Maladies négligées</term>
</keywords>
<keywords scheme="MESH" qualifier="parasitology" xml:lang="en"><term>Elephantiasis, Filarial</term>
<term>Helminthiasis</term>
<term>Neglected Diseases</term>
</keywords>
<keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Elephantiasis, Filarial</term>
<term>Helminthiasis</term>
<term>Neglected Diseases</term>
</keywords>
<keywords scheme="MESH" qualifier="standards" xml:lang="en"><term>Public Health</term>
</keywords>
<keywords scheme="MESH" qualifier="statistics & numerical data" xml:lang="en"><term>Public Health</term>
</keywords>
<keywords scheme="MESH" qualifier="therapy" xml:lang="en"><term>Neglected Diseases</term>
</keywords>
<keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Filariose lymphatique</term>
<term>Helminthiase</term>
</keywords>
<keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Albendazole</term>
<term>Antihelminthiques</term>
<term>Diéthylcarbamazine</term>
<term>Filaricides</term>
</keywords>
<keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Filariose lymphatique</term>
<term>Haïti</term>
<term>Helminthiase</term>
<term>Maladies négligées</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Animals</term>
<term>Humans</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Animaux</term>
<term>Filariose lymphatique</term>
<term>Helminthes</term>
<term>Helminthiase</term>
<term>Humains</term>
<term>Maladies négligées</term>
<term>Santé publique</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Lymphatic filariasis (LF) and soil-transmitted helminths (STH) have been targeted since 2000 in Haiti, with a strong mass drug administration (MDA) program led by the Ministry of Public Health and Population and its collaborating international partners. By 2012, Haiti's neglected tropical disease (NTD) program had reached full national scale, and with such consistently good epidemiological coverage that it is now able to stop treatment for LF throughout almost all of the country. Essential to this success have been in the detail of how MDAs were implemented. These key programmatic elements included ensuring strong community awareness through an evidence-based, multi-channel communication and education campaign facilitated by voluntary drug distributors; strengthening community trust of the drug distributors by ensuring that respected community members were recruited and received appropriate training, supervision, identification, and motivation; enforcing a "directly observed treatment" strategy; providing easy access to treatment though numerous distribution posts and a strong drug supply chain; and ensuring quality data collection that was used to guide and inform MDA strategies. The evidence that these strategies were effective lies in both the high treatment coverage obtained- 100% geographical coverage reached in 2012, with almost all districts consistently achieving well above the epidemiological coverage targets of 65% for LF and 75% for STH-and the significant reduction in burden of infection- 45 communes having reached the target threshold for stopping treatment for LF. By taking advantage of sustained international financial and technical support, especially during the past eight years, Haiti's very successful MDA campaign resulted in steady progress toward LF elimination and development of a strong foundation for ongoing STH control. These efforts, as described, have not only helped establish the global portfolio of "best practices" for NTD control but also are poised to help solve two of the most important future NTD challenges-how to maintain control of STH infections after the community-based LF "treatment platform" ceases and how to ensure appropriate morbidity management for patients currently suffering from lymphatic filarial disease.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">27706162</PMID>
<DateCreated><Year>2016</Year>
<Month>10</Month>
<Day>05</Day>
</DateCreated>
<DateCompleted><Year>2017</Year>
<Month>05</Month>
<Day>25</Day>
</DateCompleted>
<DateRevised><Year>2017</Year>
<Month>05</Month>
<Day>25</Day>
</DateRevised>
<Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1935-2735</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>10</Volume>
<Issue>10</Issue>
<PubDate><Year>2016</Year>
<Month>Oct</Month>
</PubDate>
</JournalIssue>
<Title>PLoS neglected tropical diseases</Title>
<ISOAbbreviation>PLoS Negl Trop Dis</ISOAbbreviation>
</Journal>
<ArticleTitle>Controlling Neglected Tropical Diseases (NTDs) in Haiti: Implementation Strategies and Evidence of Their Success.</ArticleTitle>
<Pagination><MedlinePgn>e0004954</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pntd.0004954</ELocationID>
<Abstract><AbstractText>Lymphatic filariasis (LF) and soil-transmitted helminths (STH) have been targeted since 2000 in Haiti, with a strong mass drug administration (MDA) program led by the Ministry of Public Health and Population and its collaborating international partners. By 2012, Haiti's neglected tropical disease (NTD) program had reached full national scale, and with such consistently good epidemiological coverage that it is now able to stop treatment for LF throughout almost all of the country. Essential to this success have been in the detail of how MDAs were implemented. These key programmatic elements included ensuring strong community awareness through an evidence-based, multi-channel communication and education campaign facilitated by voluntary drug distributors; strengthening community trust of the drug distributors by ensuring that respected community members were recruited and received appropriate training, supervision, identification, and motivation; enforcing a "directly observed treatment" strategy; providing easy access to treatment though numerous distribution posts and a strong drug supply chain; and ensuring quality data collection that was used to guide and inform MDA strategies. The evidence that these strategies were effective lies in both the high treatment coverage obtained- 100% geographical coverage reached in 2012, with almost all districts consistently achieving well above the epidemiological coverage targets of 65% for LF and 75% for STH-and the significant reduction in burden of infection- 45 communes having reached the target threshold for stopping treatment for LF. By taking advantage of sustained international financial and technical support, especially during the past eight years, Haiti's very successful MDA campaign resulted in steady progress toward LF elimination and development of a strong foundation for ongoing STH control. These efforts, as described, have not only helped establish the global portfolio of "best practices" for NTD control but also are poised to help solve two of the most important future NTD challenges-how to maintain control of STH infections after the community-based LF "treatment platform" ceases and how to ensure appropriate morbidity management for patients currently suffering from lymphatic filarial disease.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lemoine</LastName>
<ForeName>Jean Frantz</ForeName>
<Initials>JF</Initials>
<AffiliationInfo><Affiliation>Ministry of Public Health and Population, Port-au-Prince, Haiti.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Desormeaux</LastName>
<ForeName>Anne Marie</ForeName>
<Initials>AM</Initials>
<AffiliationInfo><Affiliation>Ministry of Public Health and Population, Port-au-Prince, Haiti.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Monestime</LastName>
<ForeName>Franck</ForeName>
<Initials>F</Initials>
<AffiliationInfo><Affiliation>IMA World Health, Port-au-Prince, Haiti.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Fayette</LastName>
<ForeName>Carl Renad</ForeName>
<Initials>CR</Initials>
<AffiliationInfo><Affiliation>IMA World Health, Port-au-Prince, Haiti.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Desir</LastName>
<ForeName>Luccene</ForeName>
<Initials>L</Initials>
<AffiliationInfo><Affiliation>Hôpital Sainte Croix, Léogâne, Haiti.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>University of Notre Dame, Léogâne, Haiti.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Direny</LastName>
<ForeName>Abdel Nasser</ForeName>
<Initials>AN</Initials>
<AffiliationInfo><Affiliation>RTI International, Washington, District of Columbia, United States of America.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Carciunoiu</LastName>
<ForeName>Sarah</ForeName>
<Initials>S</Initials>
<AffiliationInfo><Affiliation>IMA World Health, Washington, District of Columbia, United States of America.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Miller</LastName>
<ForeName>Lior</ForeName>
<Initials>L</Initials>
<AffiliationInfo><Affiliation>IMA World Health, Washington, District of Columbia, United States of America.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Knipes</LastName>
<ForeName>Alaine</ForeName>
<Initials>A</Initials>
<AffiliationInfo><Affiliation>Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Lammie</LastName>
<ForeName>Patrick</ForeName>
<Initials>P</Initials>
<AffiliationInfo><Affiliation>Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Smith</LastName>
<ForeName>Penelope</ForeName>
<Initials>P</Initials>
<AffiliationInfo><Affiliation>U.S. Agency for International Development, Washington, District of Columbia, United States of America.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Stockton</LastName>
<ForeName>Melissa</ForeName>
<Initials>M</Initials>
<AffiliationInfo><Affiliation>RTI International, Washington, District of Columbia, United States of America.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Trofimovich</LastName>
<ForeName>Lily</ForeName>
<Initials>L</Initials>
<AffiliationInfo><Affiliation>RTI International Consultancy, Washington, District of Columbia, United States of America.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Bhandari</LastName>
<ForeName>Kalpana</ForeName>
<Initials>K</Initials>
<AffiliationInfo><Affiliation>RTI International, Washington, District of Columbia, United States of America.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Reithinger</LastName>
<ForeName>Richard</ForeName>
<Initials>R</Initials>
<AffiliationInfo><Affiliation>RTI International, Washington, District of Columbia, United States of America.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Crowley</LastName>
<ForeName>Kathryn</ForeName>
<Initials>K</Initials>
<AffiliationInfo><Affiliation>RTI International, Washington, District of Columbia, United States of America.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Ottesen</LastName>
<ForeName>Eric</ForeName>
<Initials>E</Initials>
<AffiliationInfo><Affiliation>RTI International, Washington, District of Columbia, United States of America.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Baker</LastName>
<ForeName>Margaret</ForeName>
<Initials>M</Initials>
<AffiliationInfo><Affiliation>RTI International, Washington, District of Columbia, United States of America.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2016</Year>
<Month>10</Month>
<Day>05</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>United States</Country>
<MedlineTA>PLoS Negl Trop Dis</MedlineTA>
<NlmUniqueID>101291488</NlmUniqueID>
<ISSNLinking>1935-2727</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000871">Anthelmintics</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D005369">Filaricides</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>F4216019LN</RegistryNumber>
<NameOfSubstance UI="D015766">Albendazole</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>V867Q8X3ZD</RegistryNumber>
<NameOfSubstance UI="D004049">Diethylcarbamazine</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Bull Soc Pathol Exot. 2005 Jun;98(2):127-32</RefSource>
<PMID Version="1">16050381</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>PLoS Negl Trop Dis. 2010 Mar 23;4(3):e640</RefSource>
<PMID Version="1">20351776</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Am J Trop Med Hyg. 2005 Oct;73(4):753-8</RefSource>
<PMID Version="1">16222021</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Am J Trop Med Hyg. 2012 Mar;86(3):508-13</RefSource>
<PMID Version="1">22403327</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>PLoS Negl Trop Dis. 2008 Sep 17;2(9):e291</RefSource>
<PMID Version="1">18820740</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Afr J Health Sci. 2006 Jan-Jun;13(1-2):69-79</RefSource>
<PMID Version="1">17348745</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Bull Soc Pathol Exot Filiales. 1964 Mar-Apr;57:299-306</RefSource>
<PMID Version="1">14184782</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Malar J. 2015 Jun 05;14:237</RefSource>
<PMID Version="1">26043728</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>PLoS Negl Trop Dis. 2010 Apr 20;4(4):e668</RefSource>
<PMID Version="1">20422031</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>PLoS Negl Trop Dis. 2013 Dec 05;7(12):e2584</RefSource>
<PMID Version="1">24340120</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Trop Med Int Health. 2010 Feb;15(2):224-31</RefSource>
<PMID Version="1">20002615</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>PLoS Negl Trop Dis. 2013 Apr 11;7(4):e2080</RefSource>
<PMID Version="1">23593512</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Adv Parasitol. 2006;61:395-441</RefSource>
<PMID Version="1">16735170</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Trop Med Int Health. 2006 Nov;11(11):1731-40</RefSource>
<PMID Version="1">17054754</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Am J Trop Med Hyg. 2004 Oct;71(4):466-70</RefSource>
<PMID Version="1">15516644</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>PLoS Negl Trop Dis. 2010 Jun 29;4(6):e728</RefSource>
<PMID Version="1">20628595</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Am J Trop Med Hyg. 2007 Dec;77(6):1069-73</RefSource>
<PMID Version="1">18165524</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>PLoS Negl Trop Dis. 2014 Jul 17;8(7):e2915</RefSource>
<PMID Version="1">25032697</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>PLoS Negl Trop Dis. 2014 May 01;8(5):e2684</RefSource>
<PMID Version="1">24785993</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Infect Dis. 2003 Nov 1;188(9):1371-81</RefSource>
<PMID Version="1">14593597</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Ann Trop Med Parasitol. 2004 Oct;98(7):703-14</RefSource>
<PMID Version="1">15509424</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Trends Parasitol. 2006 Nov;22(11):529-35</RefSource>
<PMID Version="1">16971182</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Vector Borne Dis. 2010 Mar;47(1):61-4</RefSource>
<PMID Version="1">20231778</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Wkly Epidemiol Rec. 2010 Sep 17;85(38):365-72</RefSource>
<PMID Version="1">20853547</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Am J Trop Med Hyg. 2004 Nov;71(5):598-601</RefSource>
<PMID Version="1">15569791</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>PLoS Negl Trop Dis. 2011 Dec;5(12):e1366</RefSource>
<PMID Version="1">22216361</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Am J Trop Med Hyg. 2015 Dec;93(6):1292-4</RefSource>
<PMID Version="1">26503279</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Parasit Vectors. 2008 May 27;1(1):14</RefSource>
<PMID Version="1">18505577</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>PLoS Negl Trop Dis. 2008 May 14;2(5):e237</RefSource>
<PMID Version="1">18478049</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Am J Trop Med Hyg. 2006 Nov;75(5):928-32</RefSource>
<PMID Version="1">17123989</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>PLoS Negl Trop Dis. 2013 Nov 21;7(11):e2447</RefSource>
<PMID Version="1">24278486</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList><MeshHeading><DescriptorName UI="D015766" MajorTopicYN="N">Albendazole</DescriptorName>
<QualifierName UI="Q000008" MajorTopicYN="N">administration & dosage</QualifierName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000871" MajorTopicYN="N">Anthelmintics</DescriptorName>
<QualifierName UI="Q000008" MajorTopicYN="Y">administration & dosage</QualifierName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D004049" MajorTopicYN="N">Diethylcarbamazine</DescriptorName>
<QualifierName UI="Q000008" MajorTopicYN="N">administration & dosage</QualifierName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D004605" MajorTopicYN="N">Elephantiasis, Filarial</DescriptorName>
<QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
<QualifierName UI="Q000469" MajorTopicYN="N">parasitology</QualifierName>
<QualifierName UI="Q000517" MajorTopicYN="Y">prevention & control</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D005369" MajorTopicYN="N">Filaricides</DescriptorName>
<QualifierName UI="Q000008" MajorTopicYN="Y">administration & dosage</QualifierName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006205" MajorTopicYN="N">Haiti</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006373" MajorTopicYN="N">Helminthiasis</DescriptorName>
<QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
<QualifierName UI="Q000469" MajorTopicYN="N">parasitology</QualifierName>
<QualifierName UI="Q000517" MajorTopicYN="Y">prevention & control</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006376" MajorTopicYN="N">Helminths</DescriptorName>
<QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
<QualifierName UI="Q000302" MajorTopicYN="N">isolation & purification</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D058069" MajorTopicYN="N">Neglected Diseases</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
<QualifierName UI="Q000469" MajorTopicYN="N">parasitology</QualifierName>
<QualifierName UI="Q000517" MajorTopicYN="Y">prevention & control</QualifierName>
<QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011634" MajorTopicYN="N">Public Health</DescriptorName>
<QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName>
<QualifierName UI="Q000592" MajorTopicYN="N">standards</QualifierName>
<QualifierName UI="Q000706" MajorTopicYN="N">statistics & numerical data</QualifierName>
</MeshHeading>
</MeshHeadingList>
<CoiStatement>The authors have declared that no competing interests exist.</CoiStatement>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="received"><Year>2016</Year>
<Month>03</Month>
<Day>25</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted"><Year>2016</Year>
<Month>08</Month>
<Day>05</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2016</Year>
<Month>10</Month>
<Day>6</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2016</Year>
<Month>10</Month>
<Day>6</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2017</Year>
<Month>5</Month>
<Day>26</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>epublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">27706162</ArticleId>
<ArticleId IdType="doi">10.1371/journal.pntd.0004954</ArticleId>
<ArticleId IdType="pii">PNTD-D-16-00402</ArticleId>
<ArticleId IdType="pmc">PMC5051938</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
<affiliations><list><country><li>Haïti</li>
<li>États-Unis</li>
</country>
<region><li>Géorgie (États-Unis)</li>
</region>
</list>
<tree><country name="Haïti"><noRegion><name sortKey="Lemoine, Jean Frantz" sort="Lemoine, Jean Frantz" uniqKey="Lemoine J" first="Jean Frantz" last="Lemoine">Jean Frantz Lemoine</name>
</noRegion>
<name sortKey="Desir, Luccene" sort="Desir, Luccene" uniqKey="Desir L" first="Luccene" last="Desir">Luccene Desir</name>
<name sortKey="Desormeaux, Anne Marie" sort="Desormeaux, Anne Marie" uniqKey="Desormeaux A" first="Anne Marie" last="Desormeaux">Anne Marie Desormeaux</name>
<name sortKey="Fayette, Carl Renad" sort="Fayette, Carl Renad" uniqKey="Fayette C" first="Carl Renad" last="Fayette">Carl Renad Fayette</name>
<name sortKey="Monestime, Franck" sort="Monestime, Franck" uniqKey="Monestime F" first="Franck" last="Monestime">Franck Monestime</name>
</country>
<country name="États-Unis"><noRegion><name sortKey="Direny, Abdel Nasser" sort="Direny, Abdel Nasser" uniqKey="Direny A" first="Abdel Nasser" last="Direny">Abdel Nasser Direny</name>
</noRegion>
<name sortKey="Baker, Margaret" sort="Baker, Margaret" uniqKey="Baker M" first="Margaret" last="Baker">Margaret Baker</name>
<name sortKey="Bhandari, Kalpana" sort="Bhandari, Kalpana" uniqKey="Bhandari K" first="Kalpana" last="Bhandari">Kalpana Bhandari</name>
<name sortKey="Carciunoiu, Sarah" sort="Carciunoiu, Sarah" uniqKey="Carciunoiu S" first="Sarah" last="Carciunoiu">Sarah Carciunoiu</name>
<name sortKey="Crowley, Kathryn" sort="Crowley, Kathryn" uniqKey="Crowley K" first="Kathryn" last="Crowley">Kathryn Crowley</name>
<name sortKey="Knipes, Alaine" sort="Knipes, Alaine" uniqKey="Knipes A" first="Alaine" last="Knipes">Alaine Knipes</name>
<name sortKey="Lammie, Patrick" sort="Lammie, Patrick" uniqKey="Lammie P" first="Patrick" last="Lammie">Patrick Lammie</name>
<name sortKey="Miller, Lior" sort="Miller, Lior" uniqKey="Miller L" first="Lior" last="Miller">Lior Miller</name>
<name sortKey="Ottesen, Eric" sort="Ottesen, Eric" uniqKey="Ottesen E" first="Eric" last="Ottesen">Eric Ottesen</name>
<name sortKey="Reithinger, Richard" sort="Reithinger, Richard" uniqKey="Reithinger R" first="Richard" last="Reithinger">Richard Reithinger</name>
<name sortKey="Smith, Penelope" sort="Smith, Penelope" uniqKey="Smith P" first="Penelope" last="Smith">Penelope Smith</name>
<name sortKey="Stockton, Melissa" sort="Stockton, Melissa" uniqKey="Stockton M" first="Melissa" last="Stockton">Melissa Stockton</name>
<name sortKey="Trofimovich, Lily" sort="Trofimovich, Lily" uniqKey="Trofimovich L" first="Lily" last="Trofimovich">Lily Trofimovich</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/PubMed/Checkpoint

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000978 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd -nk 000978 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    LymphedemaV1
   |flux=    PubMed
   |étape=   Checkpoint
   |type=    RBID
   |clé=     pubmed:27706162
   |texte=   Controlling Neglected Tropical Diseases (NTDs) in Haiti: Implementation Strategies and Evidence of Their Success.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/RBID.i   -Sk "pubmed:27706162" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd   \
       | NlmPubMed2Wicri -a LymphedemaV1

This area was generated with Dilib version V0.6.31.
Data generation: Sat Nov 4 17:40:35 2017. Site generation: Tue Feb 13 16:42:16 2024

	Serveur d'exploration sur le lymphœdème
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration sur le lymphœdème

Controlling Neglected Tropical Diseases (NTDs) in Haiti: Implementation Strategies and Evidence of Their Success.

Controlling Neglected Tropical Diseases (NTDs) in Haiti: Implementation Strategies and Evidence of Their Success.

Source :

Descripteurs français

English descriptors

Abstract

Links toward previous steps (curation, corpus...)

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki